Imugene Ltd. (IUGNF)

Progress Continues With New Trial and ASCO Abstracts


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
June 1, 2022
Report ID: 24922
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Imugene Ltd.
Imugene Ltd.
Healthcare
Biotechnology
Ticker
IUGNF
Current Price
$0.12576 2.24%
Market Cap
$803.0M
Price Target
Refer to Report
Volume
244.2K
52wk Range
$0.0837 - $0.404
Related Research Reports
6/1/2022

Progress Continues With New Trial and ASCO Abstracts
Progress Continues With New Trial and ASCO Abstracts (IUGNF)
1/13/2022

Three Innovative Platforms That Could Change Cancer Treatment
Three Innovative Platforms That Could Change Cancer Treatment (IUGNF)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.